Back

Ultrasound molecular imaging of arterial endothelial prothrombotic changes produced by BCR-ABL-targeted tyrosine kinase inhibitors

6 December 2018 (10:15 - 10:30)
Organised by:
Congress Presentation Part of: Young Investigator Award session - Basic Science Contrast Echocardiography EACVI Premium Access EuroEcho-Imaging 2018

About the speaker

Photo
Doctor Yllka Latifi

Triemli Hospital, Zurich (Switzerland)

3 More presentations in this session

Presentation thumbnail
Epicardial adipose tissue and transforming growth factor-beta1 - risk factors of atrial fibrillation in patients with metabolic syndrome.
Assistant Professor V. Ionin (Saint Petersburg, RU)
Abstract Slides Video
Presentation thumbnail
Afterload sensitivity of global versus septal wasted work ratio: implications for prediction of cardiac resynchronization therapy response
Mr E. Willemen (Maastricht, NL)
Abstract Slides Video
Presentation thumbnail
Prognostic effect and modulation of cardiac sympathetic function in heart failure patients treated with cardiac resynchronization therapy
Doctor M. Coutinho Cruz (Lisbon, PT)
Abstract Slides Video

Access the full session

Session thumbnail
Young Investigator Award session - Basic Science

The Event

Event poster

EuroEcho-Imaging 2018

6 December 2018 10:15 CET
You may be interested in
thumbnail
Congress Presentation
Cardiovascular toxicity in CML patients treated with BCR-ABL inhibitors: relevance of early detection and management of cardiovascular follow-up
21 June 2025
thumbnail
Congress Session
Novel mechanisms for insights into atherosclerosis
26 August 2023
thumbnail
Webinar
Cancer associated thrombosis: have DOACs changed daily practice?
21 September 2021
thumbnail
Congress Presentation
Contrast echocardiography: how do I do it?
12 December 2024

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources